TECHNOLOGY, MEDICAL, and SCIENTIFIC ADVISORY BOARD

J. Michael Bishop, M.D.

Dr. Bishop is a recipient of the 1989 Nobel Prize in Medicine or Physiology for his discovery of the cellular origins of the retroviral oncogene. Specifically, he discovered the first human oncogene, c-Src, which served as a foundation for understanding how malignant tumors are formed. He is Chancellor-Emeritus of the University of California, San Francisco, and the Director of the G.W. Hooper Foundation. He is a member of the National Academy of Sciences and National Academy of Medicine. He is also a recipient of the National Medal of Science in 2003. 

 

Wee Joo Chng, M.D.

Dr. Chng is the Director of the National University Cancer Institute, Singapore. He is also the Head of the National University Cancer Institute Division of Haematology-Oncology, Deputy Director of the Cancer Science Institute of Singapore, and Leader of the Haematologic Malignancy Tumour Group of the National University Cancer Institute. His team has played a leading role in developing novel treatment strategies for haematological malignancies. He is a recipient of the NMRC Clinician Scientist Award.

 

Ali Zarrinpar, M.D., Ph.D.

Dr. Zarrinpar is a liver transplant surgeon at the UCLA Division of Liver and Pancreas and Transplantation and Dumont-UCLA Liver Transplant Center, widely regarded as among the world's pre-eminent transplant programs. He is the Director of the UCLA Liver Tissue Bank and Ischemia/Reperfusion Tissue and Blood Repository. He is an internationally-recognized researcher and has led numerous clinical studies examining novel therapies and technologies towards improved patient outcomes in liver disease and transplantation.